Hyderabad: The country is currently fighting a war against the second wave of deadly corona virus. However, now the number of new cases is declining. But deaths are still happening in large numbers. Meanwhile, a study has revealed that the indigenously developed corona virus vaccine Covaxin protects people from deadly beta (b.1.351) and delta (b.1.617.2) variants. Beta is commonly known as South African and Delta as Indian variant.
Decreased concentration of neutralizing antibodies
In research to evaluate the neutralization potential of Covaxin, researchers found a three-fold reduction in neutralization titers (concentrations of neutralizing antibodies) against beta and delta variants. That is, covaccine helps in maintaining antibodies against beta and delta variants.
A study was conducted by researchers from NIV, ICMR and Bharat Biotech. Which was uploaded to a website called biorxiv. This website publishes studies on corona and vaccine.
Who is manufacturing the vaccine
Let us tell you that Serum Institute of India, Oxford-AstraZeneca is manufacturing the Covishield vaccine. At the same time, the Hyderabad-based company Bharat Biotech is manufacturing the covaccine in collaboration with the Indian Council of Medical Research (ICMR) and the National Institute of Virology (NIV). Antibodies and their levels were examined in the blood samples of the participants of the study.
what is deltahandjob who gave the name?
The World Health Organization (WHO) first named the forms of corona virus B.1.617.1 and B.1.617.2 found in India as ‘Kappa’ and ‘Delta’ respectively. The Delta variant is even more dangerous than the ‘Alpha’ variant. The Delta (b.1.617.2) spreads 50 percent faster than the Alpha (b.1.1.7) variant. The Delta of Corona is the most prominent variant in India. In October last year, the strain (B.1.617.1) found in India was named ‘Kappa’.